Compositions and methods for increasing bone mineralization

Details for Australian Patent Application No. 2004253870 (hide)

Owner UCB Manufacturing, Inc.

Inventors Brunkow, Mary E.; Kovacevich, Brian; Van Ness, Jeffrey; Galas, David J.; Winkler, David G.; Mulligan, John T.; Paeper, Bryan W.

Agent Davies Collison Cave

Pub. Number AU-B-2004253870

PCT Pub. Number WO2005/003158

Priority 10/463,190 16.06.03 US

Filing date 15 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 10 November 2011

International Classifications

C07K 14/51 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/003158 Priority application(s): WO2005/003158

18 November 2010 Assignment before Grant

  Celltech R & D, Inc. The application has been assigned to UCB Manufacturing, Inc.

10 November 2011 Application Accepted

  Published as AU-B-2004253870

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253879-Salinosporamides and methods for use thereof

2004253869-1- (alkylaminoalkyl-pyrolidin-/piperidinyl) - 2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists